Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (161-170 of 343) with videos related to

Pageof 35
Sort By:
Cancer|August 7, 2016
Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistanceDaniel H Ahn, Milind Javle, Chul W Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based ChemotherapySunyoung Lee, Rachna T Shroff, Shalini Makawita, et al.
Cancers|June 26, 2026
Durvalumab with Gemcitabine and Oxaliplatin in Advanced Biliary Tract CancerMakenna A Smack, Jane E Rogers, Lianchun Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracilMilind M Javle, Shousong Cao, Farukh A Durrani, et al.
Annals of Surgical Oncology|June 25, 2011
Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trialMatthew H G Katz, Robert Wolff, Christopher H Crane, et al.
American Journal of Clinical Oncology|September 1, 2007
Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial resultsYehuda Z Patt, Fa-Chyi Lee, James E Liebmann, et al.
British Journal of Cancer|February 10, 2017
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancerTalia Golan, Tal Sella, Eileen M O'Reilly, et al.
Cancers|March 11, 2023
Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant OncologyKaren Abboud, Godsfavour Umoru, Abdullah Esmail, et al.
Carcinogenesis|November 17, 2020
Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterationsSung Hwan Lee, Eve B Simoneau, Tatiana Karpinets, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 29, 2006
Management of locoregional stage esophageal cancer: a single center experienceM M Javle, C E Nwogu, K A Donohue, et al.
Pageof 35

Showing results (161-170 of 343) with videos related to

Sort By:
Pageof 35
Cancer|August 7, 2016
Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistanceDaniel H Ahn, Milind Javle, Chul W Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2022
Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based ChemotherapySunyoung Lee, Rachna T Shroff, Shalini Makawita, et al.
Cancers|June 26, 2026
Durvalumab with Gemcitabine and Oxaliplatin in Advanced Biliary Tract CancerMakenna A Smack, Jane E Rogers, Lianchun Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Celecoxib and mucosal protection: translation from an animal model to a phase I clinical trial of celecoxib, irinotecan, and 5-fluorouracilMilind M Javle, Shousong Cao, Farukh A Durrani, et al.
Annals of Surgical Oncology|June 25, 2011
Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trialMatthew H G Katz, Robert Wolff, Christopher H Crane, et al.
American Journal of Clinical Oncology|September 1, 2007
Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial resultsYehuda Z Patt, Fa-Chyi Lee, James E Liebmann, et al.
British Journal of Cancer|February 10, 2017
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancerTalia Golan, Tal Sella, Eileen M O'Reilly, et al.
Cancers|March 11, 2023
Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant OncologyKaren Abboud, Godsfavour Umoru, Abdullah Esmail, et al.
Carcinogenesis|November 17, 2020
Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterationsSung Hwan Lee, Eve B Simoneau, Tatiana Karpinets, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 29, 2006
Management of locoregional stage esophageal cancer: a single center experienceM M Javle, C E Nwogu, K A Donohue, et al.
Pageof 35